stock.name

Insulet Corporation

PODD

Market Cap$11.53B
Close$

Compare Insulet

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Insulet CorporationInsulet Corporation55.90%28%6.81.9
marketMarket Avg591.3%30%-1
HealthcareHealthcare Avg64.41.34%15%-0.9
$226.00

Target Price by Analysts

37.7% upsideInsulet Target Price DetailsTarget Price
$-71.52

Current Fair Value

143.6% downside

Overvalued by 143.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$11.53 Billion
Enterprise Value$12.25 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$2.8
Beta1.06
Outstanding Shares70,022,493
Avg 30 Day Volume696,980

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio55.91
PEG11.01
Price to Sales6.84
Price to Book Ratio16.42
Enterprise Value to Revenue7.22
Enterprise Value to EBIT55.67
Enterprise Value to Net Income59
Total Debt to Enterprise0.12
Debt to Equity1.93

Revenue Sources

No data

ESG Score

No data

About Insulet Corporation

CEO: Shacey Petrovic